Remove 2005 Remove Patients Remove Treatment
article thumbnail

MS patients are being ‘denied’ access to NHS Sativex Says Media Report

Cannabis Law Report

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”. How much longer are we going to have to wait?

Access 105
article thumbnail

Meet Stefanie LaRue: Cancer Survivor and Medical Marijuana Advocate

MedicalJane

In 2005, when Stefanie was only 30, a lump was found in her breast. Stefanie once said her best advice for newly diagnosed patients was to get educated and advocate for themselves. “I In 2005, Stefanie’s world came to a halt. Stefanie declined the treatment. I would just say: Be your own voice. Be your own advocate.

Oil 95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD, THC & CBG for Skin Conditions

Project CBD

Cannabinoid-infused topicals show particular promise in the treatment of psoriasis, atopic dermatitis, and contact dermatitis. Next, the study authors review existing clinical and preclinical evidence on the effects of cannabinoid treatment for a long list of skin diseases both common and obscure. 38,3 (2005): 177-88.

article thumbnail

Marijuana-Based Parkinson’s Medication Moves Forward

CannaMD

Patients with Parkinson’s disease also frequently suffer from mood issues such as apathy and depression. For those unfamiliar, GB Sciences is a technology company that merges plant biology, cultivation, and post-production processes in order to optimize safe, consistent medical cannabis treatment. What is GB Sciences? Get Started.

article thumbnail

How Good Is Cannabis for Multiple Sclerosis (MS)?

Greencamp

Canada is one of the countries with the highest numbers of MS patients. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. However, not all patients respond to these treatments well enough, and some don’t respond at all.

article thumbnail

Jason Straw: Medical Cannabis Policy, ISNA 2020 Conference

Cannabis Law Report

Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. The findings of anecdotal and controlled studies regarding the efficacy for patient use are mixed. ISNA 2020- Jason Straw- Medical Cannabis Policy.

Policy 81
article thumbnail

Why we haven’t cured cancer

Otherside Farms

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full – 2005). abst – 2005).